Novelion Therapeutics Inc. announced the appointment of John J. Orloff, M.D. to its board of directors, effective as of July 1, 2017. Dr. Orloff will resign as Novelion’s Executive Vice President and Head of Research and Development. Dr. Orloff will continue to provide guidance to the management team regarding the company’s scientific strategy and clinical program development, and will assume a significant role in the oversight of the company as a member of its Board of Directors.